Myelofibrosis | Myeloid Metaplasia | Myelofibrosis Transformation in Essential Thrombocythemia | Myelofibrosis; Anemia | Myelofibrosis，MF | Myelofibrosis Due to and Following Polycythemia Vera | Myelofibrosis With Myeloid Metaplasia | Myelofibrosis With High Molecular Risk Mutations | Myelofibrosis,... and other conditions
John Mascarenhas
National Cancer Institute (NCI); Syndax Pharmaceuticals
United States, Canada, Taiwan, Spain, Italy, Israel, India, Belgium, Ireland, Greece, Bulgaria, Sweden, Malaysia, France, United Kingdom, Austria, Saudi Arabia, Germany, Australia, South Korea, Japan, Argentina, Romania, Brazil, Turkey... and more
This is a preview
Log in or create a free account to see all matching trials and use the full search.
